Female Urology

"I think there's going to be a rapid adoption of artificial intelligence platforms in our field," says David Sheyn, MD.

"It is a big ask of a trainee to have them sign up for a field that is demanding in terms of training, but also demanding in terms of non-professional commitments that they would otherwise make to their family life and their personal life," says Akanksha Mehta, MD, MS.

"UH is working on starting clinics throughout rural Northeast Ohio, and we're meeting to develop a FPMRS program, both virtual and in-person, so patients can have access to this point of care," says David Sheyn, MD.

"UH is working on starting clinics throughout rural Northeast Ohio, and we're meeting to develop a FPMRS program, both virtual and in-person, so patients can have access to this point of care," says David Sheyn, MD.

"Given that PCR testing may have a benefit for specific cohorts, it is recommended that more clinical evidence be provided to better guide Medicare in defining 'medical necessity,' ” write Stephanie Gleicher, MD, MPH, and Roger R. Dmochowski MD, MMHC, FACS.

Urinary tract infections (UTIs) are among the most common human infections. But the urine culture, the cornerstone for laboratory diagnosis of UTI, is imperfect.

The American Urogynecologic Society has developed the following guidelines, committee opinions, and statements to promote the highest quality patient care in FPMRS.

“I would just burn it into everyone's brain that pain with intercourse is also going to be associated with genitourinary syndrome of menopause,” says Rachel Pope, MD, MPH.

Black race was identified as an independent predictor of 30-day readmission even after investigators controlled for differences in patient demographics, clinical factors, and comorbidities.

The study considered 4 dimensions of the workplace: equal access, work-life balance, freedom from gender bias, and supportive leadership.

The patient-focused book entitled Pelvic Floor Health: Your Guide to Pregnancy and Postpartum Care is now available in paperback and e-book.

“We need to be focusing our efforts on early exposure to the field for women and underrepresented groups,” says Bridget Lang Findlay, MD.

Dr. Van Kuiken discusses 2022 milestones in FPMRS and looks ahead to what might be on the horizon for the field in the coming year.

“The bottom line is that [gender parity] starts with sponsorship and bringing women to the table in academic leadership positions so that our voices can be heard,” says Bridget Lang Findlay, MD.

The American Urogynecologic Society's Pelvic Floor Disorders (PFD) Week 2023 is the year’s largest venue for those in the field of urogynecology and Female Pelvic Medicine and Reconstructive Surgery to come together for education and networking.

There are several elements of ERAS with strong evidence of benefit in urogynecological surgery.

The phase 3 EAGLE-2 and EAGLE-3 studies looked at outcomes for gepotidacin, an investigational agent for the treatment of uncomplicated urinary tract infection.

Register for AUGS Clinical Meeting 2022, Beyond Urogynecology: Pearls for Best Practice.

The FDA decided a New Drug Application lacked sufficient data to approve tebipenem pivoxil hydrobromide (tebipenem HBr) for the treatment of patients with complicated urinary tract infection.

In this interview, coauthors Connie Huang, MD, and Jason M. Kim, MD, discuss the findings of their recent study, "Urinary Tract Infection on social media: Examining YouTube content as a source of patient educational information."

“We know that, in general, cystectomy in women can disrupt pelvic floor support and innervation, as well as hormonal and sexual function, but there are no good prospective data to help us fully understand pelvic floor complications following the procedure,” said Jacqueline Zillioux, MD.

The FDA is evaluating a new drug application for oral tebipenem pivoxil hydrobromide for the treatment of patients with complicated urinary tract infection, including acute pyelonephritis.

“I think we as urologists have to be proactive in providing information to our patients so that they avoid financial harm and potentially bodily harm from this sort of misinformation,” says Rena D. Malik, MD.

A study presented at the 2022 Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) Winter Meeting evaluated the safety and efficacy of percutaneous tibial nerve stimulation (PTNS) in patients who suffer from female sexual dysfunction.

Jerry G. Blaivas, MD, FACS, debunks some of the common stigmas associated with mesh slings.